Pelargonium sidoides
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2019 (NCT06353477)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07017335 | Phase 1 | Jun 1, 2025 | Pharmbio Korea |
| NCT06353477 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2019 | Abdi Ibrahim Pharmaceuticals, Eskisehir Osmangazi University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abdi Ibrahim Pharmaceuticals | For profit | 1 | 0 | 1 | 2019 |
| Eskisehir Osmangazi University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Pharmbio Korea | For profit | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1